(Q74779834)
Statements
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison (English)
W Kern
C Aul
G Maschmeyer
R Schönrock-Nabulsi
W D Ludwig
A Bartholomäus
P Bettelheim
B Wörmann
T Büchner